Laura de Arroyo Garcia supports complex commercial and strategic advisory matters for organizations operating in the life sciences, biotechnology, medical devices, health care, and consumer sectors. She advises clients across a broad range of regulatory, intellectual property, technology, and data-related issues, including new product and service launches, and IP-heavy transactions, regulatory change, and the deployment of emerging technologies (including artificial intelligence, digital platforms, and Internet of Things).
Laura has a strong technical background in bioinformatics, computational biology, and synthetic biology, as well as entrepreneurial experience gained as part of an Imperial College spinout. She combines leading sector experience with rigorous academic training in the life sciences, enabling her to provide commercially informed guidance across a wide range of legal issues.
Laura serves as a committee member of the Imperial College London Research Ethics Committee, which reviews medium and high-risk research involving human participants undertaken at the college.
Laura's experience also encompasses patent litigation, information security, and digital regulation spanning adtech, online safety, and cyber regulatory matters. Prior to joining Jones Day in 2026, she spent significant time on a secondment to a global technology company and a global automotive company.
经验
- BPP Law School, London (LL.M. in Commercial Legal Practice 2021; Graduate Diploma in Law 2020); Imperial College London (Ph.D. in Biotechnology 2021; M.Sc. in Bioinformatics and Theoretical Systems Biology 2016; B.Sc. in Biotechnology and Management 2015)
- Solicitor of the Senior Courts of England and Wales
- Spanish and French
发送前请注意
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice